Last Updated on February 12, 2021 by The Health Master
Glenmark Pharmaceuticals Limited has received final approval from United States Food & Drug Administration (USFDA) for clindamycin phosphate gel USP, 1%, the generic version of Cleocin T gel, 1%, of Pharmacia & Upjohn.
According to IQVIA sales data for the 12 month period ending December 2020, the Cleocin T gel, 1% market achieved annual sales of approximately $73.8 million.
Glenmark’s current portfolio consists of 169 products authorized for distribution in the US marketplace and 42 ANDA’s pending approval with the USFDA.
In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.
Go to main website, click here
Subscribe for daily free updates, click here
For daily free updates on WhatsApp, click here